Quick Answer
Krystal Biotech, Inc. reported Operating Income of $161.29 million for fiscal year 2025.
Krystal Biotech, Inc. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | $161.29M | +145.3% |
| 2024 | $65.75M | +160.0% |
| 2023 | -$109.62M | +24.5% |
| 2022 | -$145.20M | -112.7% |
| 2021 | -$68.28M | -106.9% |
| 2020 | -$33.00M | -49.4% |
| 2019 | -$22.08M | -85.3% |
| 2018 | -$11.92M | -149.7% |
| 2017 | -$4.77M | -317.5% |
| 2016 | -$1.14M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $41.37M | +84.1% | +5.3% |
| June 30, 2025 | $39.31M | +358.9% | +8.7% |
| March 31, 2025 | $36.18M | +641.2% | +61.0% |
| September 30, 2024 | $22.47M | +186.5% | +162.3% |
| June 30, 2024 | $8.57M | +122.5% | +228.2% |
| March 31, 2024 | -$6.68M | +86.3% | +74.3% |
| September 30, 2023 | -$25.99M | +17.4% | +31.7% |
| June 30, 2023 | -$38.05M | -32.3% | +22.1% |
- Krystal Biotech, Inc. showed an increase of +145.3% in Operating Income compared to the prior fiscal year.
- Over the 2016–2025 period, Krystal Biotech, Inc.’s operating income has grown by 14211.5% (from -$1.14 million to $161.29 million).
- The most recent figure is from Krystal Biotech, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 17, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: